Literature DB >> 33575914

Transient Delivery of a KCNQ2/3-Specific Channel Activator 1 Week After Noise Trauma Mitigates Noise-Induced Tinnitus.

Laura Marinos1, Stylianos Kouvaros1, Brandon Bizup1, Bryce Hambach1, Peter Wipf2, Thanos Tzounopoulos3.   

Abstract

Exposure to loud noise can cause hearing loss and tinnitus in mice and humans. In mice, one major underlying mechanism of noise-induced tinnitus is hyperactivity of auditory brainstem neurons, due at least in part, to decreased Kv7.2/3 (KCNQ2/3) potassium channel activity. In our previous studies, we used a reflex-based mouse model of tinnitus and showed that administration of a non-specific KCNQ channel activator, immediately after noise trauma, prevented the development of noise-induced tinnitus, assessed 1 week after trauma. Subsequently, we developed RL-81, a very potent and highly specific activator of KCNQ2/3 channels. Here, to test the timing window within which RL-81 prevents tinnitus in mice, we modified and employed an operant animal model of tinnitus, where mice are trained to move in response to sound but not move in silence. Mice with behavioral evidence of tinnitus are expected to move in silence. We validated this mouse model by testing the effect of salicylate, which is known to induce tinnitus. We found that transient administration of RL-81 1 week after noise exposure did not affect hearing loss but reduced significantly the percentage of mice with behavioral evidence of tinnitus, assessed 2 weeks after noise exposure. Our results indicate that RL-81 is a promising drug candidate for further development for the treatment of noise-induced tinnitus.

Entities:  

Keywords:  KCNQ potassium channel activators; auditory brainstem; cochlea; hearing loss; therapeutic window; tinnitus

Mesh:

Substances:

Year:  2021        PMID: 33575914      PMCID: PMC7943662          DOI: 10.1007/s10162-021-00786-3

Source DB:  PubMed          Journal:  J Assoc Res Otolaryngol        ISSN: 1438-7573


  35 in total

1.  Expression of COX-2 and NMDA receptor genes at the cochlea and midbrain in salicylate-induced tinnitus.

Authors:  Juen-Haur Hwang; Jin-Cherng Chen; Shan-Ying Yang; Ming-Fu Wang; Tien-Chen Liu; Yin-Ching Chan
Journal:  Laryngoscope       Date:  2011-01-13       Impact factor: 3.325

2.  Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus.

Authors:  Bopanna I Kalappa; Heun Soh; Kevin M Duignan; Takeru Furuya; Scott Edwards; Anastasios V Tzingounis; Thanos Tzounopoulos
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

3.  An Investigation into Retigabine (Ezogabine) Associated Dyspigmentation in Rat Eyes by MALDI Imaging Mass Spectrometry.

Authors:  M Reid Groseclose; Stephen Castellino
Journal:  Chem Res Toxicol       Date:  2019-01-31       Impact factor: 3.739

Review 4.  Towards a Mechanistic-Driven Precision Medicine Approach for Tinnitus.

Authors:  Thanos Tzounopoulos; Carey Balaban; Lori Zitelli; Catherine Palmer
Journal:  J Assoc Res Otolaryngol       Date:  2019-03-01

5.  Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K+ currents in neurons.

Authors:  Fabio A Vigil; Eda Bozdemir; Vladislav Bugay; Sang H Chun; MaryAnn Hobbs; Isamar Sanchez; Shayne D Hastings; Rafael J Veraza; Deborah M Holstein; Shane M Sprague; Chase M Carver; Jose E Cavazos; Robert Brenner; James D Lechleiter; Mark S Shapiro
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-04       Impact factor: 6.200

Review 6.  Novel Treatment and New Drugs in Epilepsy Treatment.

Authors:  Elissavet Eskioglou; Matthieu P Perrenoud; Philippe Ryvlin; Jan Novy
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

7.  Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.

Authors:  Manoj Kumar; Nicholas Reed; Ruiting Liu; Elias Aizenman; Peter Wipf; Thanos Tzounopoulos
Journal:  Mol Pharmacol       Date:  2016-03-22       Impact factor: 4.436

8.  Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons.

Authors:  Brian J Wainger; Evangelos Kiskinis; Cassidy Mellin; Ole Wiskow; Steve S W Han; Jackson Sandoe; Numa P Perez; Luis A Williams; Seungkyu Lee; Gabriella Boulting; James D Berry; Robert H Brown; Merit E Cudkowicz; Bruce P Bean; Kevin Eggan; Clifford J Woolf
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

Review 9.  Driving with no brakes: molecular pathophysiology of Kv7 potassium channels.

Authors:  Maria Virginia Soldovieri; Francesco Miceli; Maurizio Taglialatela
Journal:  Physiology (Bethesda)       Date:  2011-10

10.  Expression of tumor necrosis factor-α and interleukin-1β genes in the cochlea and inferior colliculus in salicylate-induced tinnitus.

Authors:  Juen-Haur Hwang; Jin-Cherng Chen; Shan-Ying Yang; Ming-Fu Wang; Yin-Ching Chan
Journal:  J Neuroinflammation       Date:  2011-04-09       Impact factor: 8.322

View more
  1 in total

Review 1.  What's the buzz? The neuroscience and the treatment of tinnitus.

Authors:  A Henton; T Tzounopoulos
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.